128 related articles for article (PubMed ID: 6138435)
1. beta 1-selective adrenoceptor antagonists. 2. 4-ether-linked phenoxypropanolamines.
Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Fryer AD; Melarange RA; Shivdasani C
J Med Chem; 1983 Nov; 26(11):1570-6. PubMed ID: 6138435
[TBL] [Abstract][Full Text] [Related]
2. Beta 1-selective adrenoceptor antagonists. 3. 4-Azolyl-linked phenoxypropanolamines.
Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Melarange RA
J Med Chem; 1984 Apr; 27(4):503-9. PubMed ID: 6142955
[TBL] [Abstract][Full Text] [Related]
3. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
[No Abstract] [Full Text] [Related]
7. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
8. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
[TBL] [Abstract][Full Text] [Related]
9. Relationships between conformational behaviour and binding affinity towards beta 1 and beta 2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents.
Villa L; Villa AM; Pallavicini M; Romeo S; Valoti E; Ferri V; Iuliano E; Brunello N
Farmaco; 1995 Oct; 50(10):643-58. PubMed ID: 8590572
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols.
Barlow JJ; Main BG; Snow HM
J Med Chem; 1981 Mar; 24(3):315-22. PubMed ID: 6115058
[TBL] [Abstract][Full Text] [Related]
12. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
Mylecharane EJ; Raper C
Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
[No Abstract] [Full Text] [Related]
13. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
[TBL] [Abstract][Full Text] [Related]
14. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
Zakhari S
Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
[No Abstract] [Full Text] [Related]
15. Binding and functional affinity of some newly synthesized phenethylamine and phenoxypropanolamine derivatives for their agonistic activity at recombinant human beta3-adrenoceptor.
Ahmed M; Hanaoka Y; Nagatomo T; Kiso T; Kakita T; Kurose H; Nagao T
J Pharm Pharmacol; 2003 Jan; 55(1):95-101. PubMed ID: 12625872
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bovine beta 3-adrenergic agonistic activities of a novel series of aryloxypropanolamines.
el Hadri A; Nicolle E; Guillaume MC; Leclerc G; Pietri-Rouxel F; Strosberg AD; Archimbault P
Pharmazie; 2001 Jul; 56(7):517-22. PubMed ID: 11487967
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
18. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
Smith LH; Tucker H
J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
[TBL] [Abstract][Full Text] [Related]
19. Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to block beta-adrenoceptors and induce sympathomimetic action.
Takayanagi I; Ogishima M; Koike K; Hisayama T; Hayashida M; Fujii M
Gen Pharmacol; 1989; 20(4):417-9. PubMed ID: 2568966
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle.
Lezama EJ; Konkar AA; Salazar-Bookaman MM; Miller DD; Feller DR
Eur J Pharmacol; 1996 Jul; 308(1):69-80. PubMed ID: 8836634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
